As the demand for these granules increased, so did Abbott Alkaloidal Company, and one of the world's most broad-based healthcare companies was born. By 1910, there were over 700 new products in ...

ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

2024 Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks.

Abbott Labs is the company behind consumer nutrition brands ... we can see from Statista data that in 2024 the medical devices and products sector added $0.7T of value in 2024, while a projected ...

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

However, the company’s ability to pivot ... a 22% discount to the Zacks Medical Products industry average of 5.6X. This valuation is below Abbott's five-year median of 4.74X, indicating that ...

While the pandemic caused some of Abbott's segments to balloon ... its ability to consistently introduce innovative products. On margins, the company has made progress over the past 10 years ...

In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...